Back

Cardiac resynchronization therapy: need to synchronize patients and device longevities with comorbidities

EP Europace Journal

27 December 2018
Organised by: Logo
Read full article
ESC Journals

Contributors

Giuseppe Boriani
Giuseppe Boriani

Author

Marco Vitolo
Marco Vitolo

Author

Valentina Kutyifa
Valentina Kutyifa

Author

University of Rochester Rochester , United States of America

You may be interested in
thumbnail
Webinar
New 2021 HF guidelines - what is new for device therapies and how to optimally combine new HF drugs with ICD-CRTDs
16 February 2023
thumbnail
Congress Presentation
Impact of comorbidities on survival and complications in patients implanted with leadless pacemakers: a national, multicenter study
8 April 2024
thumbnail
Congress Presentation
Natural history of resynchronized patients: experience of a single centre
29 June 2021
thumbnail
Congress Presentation
Development of a risk stratification score for cardiac resynchronization therapy patients based on social predictors by multidisciplinary evaluation
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources